Skip to Main Content

Author Details

Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
1990
48
19
PMIDPaper TitleJournal TitlePublished Year
36343786UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.Cancer Lett2023
37190147Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.Cancers (Basel)2023
37086156Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.Mol Oncol2023
37435060High infiltration of CD209<sup>+</sup> dendritic cells and CD163<sup>+</sup> macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.Front Immunol2023
35075795Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor-associated macrophage phenotype.Clin Transl Med2022
35598879Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion.Mol Metab2022
36246841Combining Antiandrogens with Immunotherapy for Bladder Cancer Treatment.Eur Urol Open Sci2022
32676741Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.World J Urol2021
34944863Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.Cancers (Basel)2021
34588590Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs.Sci Rep2021
34575920Identification of Abundant and Functional dodecaRNAs (doRNAs) Derived from Ribosomal RNA.Int J Mol Sci2021
34743445Dimensional reduction based on peak fitting of Raman micro spectroscopy data improves detection of prostate cancer in tissue specimens.J Biomed Opt2021
33276284Long chain omega-3 fatty acids and their oxidized metabolites are associated with reduced prostate tumor growth.Prostaglandins Leukot Essent Fatty Acids2021
33262291Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity.Mol Cancer Res2021
32797086Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: A diagnostic accuracy case-control study with multicohort validation.PLoS Med2020
33299664Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.Oncoimmunology2020
33324443Identification of a Transcriptomic Prognostic Signature by Machine Learning Using a Combination of Small Cohorts of Prostate Cancer.Front Genet2020
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
30073695Omega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated mice.Prostate2019
31265453Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.PLoS Med2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
31018850Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.Radiat Oncol2019
31156708Large-Scale Automatic Feature Selection for Biomarker Discovery in High-Dimensional OMICs Data.Front Genet2019
28972698Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.BJU Int2018
30200929The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.BMC Urol2018
29603326The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival.Prostate2018
28068672Genomic hallmarks of localized, non-indolent prostate cancer.Nature2017
28511883A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.Eur Urol2017
27815082Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.Eur Urol2017
26759009Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer.Cancer Immunol Immunother2016
26645279Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.Cancer Prev Res (Phila)2016
27604597Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.Cancer Immunol Res2016
24892030IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness.Res Rep Urol2014
25371605Cystatin C for early detection of acute kidney injury after laparoscopic partial nephrectomy.Urol Ann2014
23574787High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.Hum Pathol2013
23979666Toll-like receptors in urothelial cells--targets for cancer immunotherapy.Nat Rev Urol2013
21421234Toll-like receptors in normal and malignant human bladders.J Urol2011
19193487Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.Eur Urol2009
19533752High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer.Int J Cancer2009
17290406MAGE-A9 mRNA and protein expression in bladder cancer.Int J Cancer2007
16516037Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.J Urol2006
17069033Cancer-testis antigen expression in bladder cancer.Prog Urol2006
16734221Cancer-testis antigen expression in bladder cancer.Prog Urol2005
9032480Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization.Biochem J1997
9185702Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer.Int J Cancer1997
8631032Identification of a superficial bladder tumor-associated glycoform of the carcinoembryonic antigen by monoclonal antibody 19A211.Cancer Res1996
8636121MAUB is a new mucin antigen associated with bladder cancer.J Biol Chem1996
1701166Monoclonal antibody against a tumor-associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas.Int J Cancer1990
  • 1 - 48 of 48

Recommended Authors

University of California San Francisco
Career Start Year 2014
Number of shared co-authors 1
University of Toronto
Career Start Year 2012
Number of shared co-authors 11
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 14
Mount Sinai Hospital, University of Toronto, University Health Network
Career Start Year 2007
Number of shared co-authors 9
University of Toronto
Career Start Year 2006
Number of shared co-authors 16
University of British Columbia
Career Start Year 2004
Number of shared co-authors 9
the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
Career Start Year 2002
Number of shared co-authors 11
University of California
Career Start Year 1996
Number of shared co-authors 2
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 0
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 3
Career Start Year 1995
Number of shared co-authors 18
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 12
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 19
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 9
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 16
The University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 8
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 3
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 14
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 9
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 1
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 19
The University of Texas MD Anderson Cancer Center
Career Start Year 1985
Number of shared co-authors 0
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 8
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 11
Queen's University
Career Start Year 1982
Number of shared co-authors 31
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 13
Purdue University
Career Start Year 1978
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1977
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 4

Collaborators

CHU de Quebec-Universite Laval
Co-authored papers 44
CHU de Quebec-Universite Laval
Co-authored papers 20
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 19
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 12
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 12
Institut du cancer de Montreal
Co-authored papers 10
University Health Network, University of Toronto
Co-authored papers 10
University of Montreal Health Center
Co-authored papers 8
University of California los angeles
Co-authored papers 8
University of Toronto
Co-authored papers 8
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Co-authored papers 7
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 7
Centre de Recherche du CHU de Quebec-Universite, Universite Laval
Co-authored papers 5
University of California los angeles
Co-authored papers 5
National Cancer Centre Singapore
Co-authored papers 5
University of Toronto
Co-authored papers 5
Centre hospitalier de l'Universite de Montreal
Co-authored papers 5
Centre de recherche du Centre hospitalier universitaire de Quebec-Universite Laval
Co-authored papers 4
Institut de Pathologie Multisite
Co-authored papers 4
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)
Co-authored papers 4
University of British Columbia
Co-authored papers 4
Centre de recherche du Centre hospitalier de l'Universite de Montreal
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3
University of British Columbia
Co-authored papers 3
McGill University Health Centre, McGill University
Co-authored papers 3
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 3
CHU de Quebec-Laval University Research Center
Co-authored papers 3
Tufts University School of Medicine
Co-authored papers 3